Clinical Trial Update: CD19 CAR-T Cell Infusion as Consolidation Therapy in Adolescent and Adult Patients With Acute B-ALL Ineligible for Allogeneic HSCT: A Clinical Study [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial investigates CD19 CAR-T cell infusion as consolidation therapy for adolescents and adults with acute lymphoblastic leukemia ineligible for a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• CD19 CAR-T cell infusion (CAR-T cell therapy targeting CD19)

Snippet

Sponsor: Zhujiang Hospital | Conditions: Acute Lymphoblastic Leukemia | Phase 1, Phase 2 | Status: RECRUITING